LABORATORY CORPORATION OF AMERI (0JSY.L) Financials
0JSY.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 16.9 billion | 9.0 billion |
| 2023-06-30 | 17.7 billion | 8.9 billion |
| 2023-03-31 | 20.2 billion | 9.8 billion |
0JSY.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 280.0 million | 200000 |
| 2023-06-30 | 139.4 million | ? |
| 2023-03-31 | 27.3 million | 67.3 million |
0JSY.L Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -167.1 million |
| 2023-09-30 | 183.3 million |
| 2023-06-30 | 188.9 million |
| 2023-03-31 | 212.9 million |
0JSY.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 727.9 million | - | - |
| 2023-06-30 | 1.9 billion | - | - |
| 2023-03-31 | 393.9 million | - | - |
0JSY.L Shares Outstanding
0JSY.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 104.9 million | - | - | - |
| 2023-06-30 | 102.6 million | - | - | - |
| 2023-03-31 | 93.9 million | - | - | - |
0JSY.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | 3.1 billion | 2.2 billion |
| 2023-06-30 | 3.0 billion | 2.2 billion |
| 2023-03-31 | 3.0 billion | 2.2 billion |
0JSY.L
Price: $193.20
Dividend Yield: 0.01%
Forward Dividend Yield: 1.49%
Payout Ratio: 13.22%
Dividend Per Share: 2.88 USD
Earnings Per Share: 21.78 USD
P/E Ratio: 10.25
Exchange: LSE
Sector: Healthcare
Industry: Health Care Equipment & Services
Market Capitalization: 205.1 million
Average Dividend Frequency: 5
Years Paying Dividends: 3